Antioxidant Therapies in the Treatment of Aminoglycoside‐Induced Ototoxicity: A Meta‐Analysis
The Laryngoscope · 2025
DOI: 10.1002/lary.31902 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Laryngoscope, 2025. Verfasst von Patrick J Gaffney und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Aminoglycosides, Antioxidants, Ototoxicity, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Objective
A feared complication of aminoglycoside treatment is ototoxicity, which is theorized to be attributed to the production of aminoglycoside‐induced reactive oxygen species. Previous studies using animal models have suggested that numerous therapies targeting reducing oxidative stress may prevent ototoxicity from aminoglycosides. However, few clinical studies have been conducted on these antioxidants. This systematic review and meta‐analysis examines the effectiveness of antioxidant therapies in the treatment of aminoglycoside‐induced ototoxicity. Data Sources PubMed, Embase, Web of Science, and ClinicalTrials.gov . Review Method A literature search was conducted in August 2024. This review sought randomized controlled trials to be conducted on humans to examining otologic outcomes in aminoglycoside‐induced ototoxicity following administration of medications intended to reduce oxidative stress.
Results
A systematic review yielded 2037 results, of which seven studies met inclusion criteria. N‐acetylcysteine (NAC) was investigated in four studies, aspirin in two studies, and vitamin E in one study. Six studies examined the benefit of antioxidant treatments for up to 8 weeks after administration while one study tested subjects' hearing after 1 year. In pooled analysis, two studies assessing NAC showed the greatest reduction in ototoxicity (RR 0.112, 95% CI, 0.032–0.395; p = 0.0007; I 2 = 18%), followed by two studies examining aspirin (RR 0.229, 95% CI, 0.080–0.650; p = 0.0057; I 2 = 0%). One study performed with vitamin E did not find a reduction in ototoxicity compared to the placebo (RR 0.841, 95% CI, 0.153–4.617; p = 0.8416).
Conclusions
Multiple studies have shown that NAC and aspirin are effective in reducing ototoxicity from treatment with aminoglycosides. However, there is a lack of high‐quality evidence. Additional studies should examine whether aspirin and N‐acetylcysteine provide long‐term benefit, and which of the other promising antioxidants translate from animal models. Level of Evidence NA Laryngoscope , 135:1278–1286, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology - Head and Neck Surgery, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Patrick J Gaffney
Zitieren
APA
Gaffney, P. J., Shetty, K. R., Yuksel, S., & Kaul, V. F. (2025). Antioxidant Therapies in the Treatment of Aminoglycoside‐Induced Ototoxicity: A Meta‐Analysis. The Laryngoscope. https://doi.org/10.1002/lary.31902
Vancouver
Gaffney PJ, Shetty KR, Yuksel S, Kaul VF. Antioxidant Therapies in the Treatment of Aminoglycoside‐Induced Ototoxicity: A Meta‐Analysis. The Laryngoscope. 2025. doi:10.1002/lary.31902
BibTeX
@article{Gaffney2025,
author = {Gaffney, Patrick J and Shetty, Kunal R and Yuksel, Sancak and Kaul, Vivian F},
title = {Antioxidant Therapies in the Treatment of Aminoglycoside‐Induced Ototoxicity: A Meta‐Analysis},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.31902}
}
EUVIMED